Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06072066 · ClinicalTrials.gov registry record · NA
Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea
A NA study of Rosacea and Systemic Inflammation, sponsored by Integrative Skin Science and Research.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06072066: Recruiting NA study of Rosacea and Systemic Inflammation, sponsored by Integrative Skin Science and Research.
NCT06072066 is a NA study of Rosacea and Systemic Inflammation that is actively recruiting participants, run by Integrative Skin Science and Research. The registered enrollment target is 24 participants, below the 242-participant average among 23 other Rosacea trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06072066, a NA study of Rosacea and Systemic Inflammation, is actively recruiting participants, sponsored by Integrative Skin Science and Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how supplementation will alter the skin and the gut barrier and inflammation in those with rosacea.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Skin Barrier Oral Supplement
Study Locations (1)
California
- Integrative Skin and Research - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-11-22 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What NCT06072066 shows while recruiting
NCT06072066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 242-participant average among 23 other Rosacea trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Rosacea appearing as the primary indexed condition, and to 1 intervention - of which Skin Barrier Oral Supplement is the first listed.
NCT06072066 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06072066 about?
NCT06072066 is a clinical study titled "Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea". The purpose of this study is to evaluate how supplementation will alter the skin and the gut barrier and inflammation in those with rosacea.
What is the current status of trial NCT06072066?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-11-22. Estimated completion is 2024-12-31.
What conditions does trial NCT06072066 study?
This clinical trial studies the following conditions: Rosacea, Systemic Inflammation.
What interventions are being tested in trial NCT06072066?
The interventions under investigation include: Skin Barrier Oral Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06072066?
This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06072066 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06072066's enrollment target sits among peer trials
24 22nd of 23 higher than 2 of 23 other Rosacea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rosacea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
COMPLETED · NA
-
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
COMPLETED · NA
-
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
RECRUITING · Phase 2
-
Analysis of the Microbiome in Rosacea
ACTIVE NOT RECRUITING · Early Phase 1
-
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI